More jobs:
Physician - Hematologic Malignancies - Scientist - Immune Effector Cell Therapy
Job in
Westwood, Johnson County, Kansas, USA
Listed on 2026-06-02
Listing for:
The University of Kansas Health System
Full Time
position Listed on 2026-06-02
Job specializations:
-
Science
Clinical Research, Medical Science
Job Description & How to Apply Below
Position Title
Physician - Hematologic Malignancies - Scientist - Immune Effector Cell Therapy
Westwood Medical Pavilion - West
Position Summary / Career Interest:
Physician - Hematologic Malignancies - Scientist - Immune Effector Cell Therapy
The University of Kansas Health System and The University of Kansas Cancer Center, are seeking a Scientist in Immune Effector Cell Therapy to join the Division of Hematologic Malignancies & Cellular Therapeutics.
The University of Kansas Cancer Center (KUCC) is the only NCI-designated Comprehensive Cancer Center in the region, serving patients across Kansas and western Missouri. The program includes the region's largest Blood and Marrow Transplant and Cellular Immunotherapy program, providing a strong clinical and translational platform for innovative immune effector cell research.
The selected candidate will benefit from exceptional institutional resources, including a new state-of-the-art cancer center currently under construction to support cutting-edge research and multidisciplinary care. This full-time, research-track faculty position offers academic rank commensurate with experience, competitive salary and comprehensive benefits, dedicated start-up support, and access to institutional core facilities within a highly collaborative campus environment.
This is a unique opportunity to shape the future of cancer immunotherapy by driving translational research at the interface of discovery science, preclinical development, and early-phase clinical trials. The successful candidate will contribute to next-generation immune effector strategies, including CAR-T and CAR-NK therapies, engineered macrophages/monocytes, and combination immunotherapies for hematologic and solid tumors.
Key Responsibilities:
- Establish an innovative and externally funded research program.
- Design, lead and execute translational studies in immune-effector cell therapy (e.g., CAR constructs, BiTEs, "armored" cells, logic-gated circuits) that enable generation of patentable IEC intellectual property.
- Recruit additional faculty to expand research within the IEC program.
- Design and oversee in vitro functional assays (killing, cytokine profiling, spectral flow, scRNA-seq/CITE-seq) and in vivo preclinical efficacy/toxicity models.
- Collaborate with KUCC's cGMP manufacturing, the Institute for Advancing Medical Innovation (IAMI), Clinical Trials Office, Pathology, and Biostatistics to advance First-in-Human, enabling investigational new drug submissions to FDA and lead/participate in IEC early phase clinical trials.
- Develop and validate analytical/quality assays (potency, identity, vector copy number, sterility/mycoplasma, off-target/tropism assessments).
- Contribute to the preparation of regulatory documentation (IACUC/IRB, Biosafety, IND/IDE modules), study protocols, and clinical correlative science plans.
- Mentor trainees (graduate students, residents, postdocs and fellows) as well as junior faculty and coordinate cross-functional project teams.
- Disseminate results via manuscripts, conference abstracts, and grant applications (NIH, LLS, foundations).
- MD, DO, MD/PhD, or PhD in Immunology, Hematology/Oncology;
Cancer Biology, Bioengineering, or related field - 2-5 years post-degree research experience in immune-effector cell therapy or closely related area
- Hands-on expertise in cell engineering (viral/non-viral delivery; CRISPR or equivalent), primary T/NK cell culture, and functional immunology assays
- Previous extramural funding: i.e., K award, R21, DOD
- Demonstrated track record of impactful publications and team-based science
- Experience with CAR/TCR design, multiplex editing, payload/armoring strategies (e.g., IL-15, TGF-β-DN), or innate cell engineering (CAR-macrophage)
- Familiarity with GMP principles, release testing, and tech transfer to manufacturing
- Experience with glial/solid tumor models and strategies to overcome antigen heterogeneity/immune suppression
- Comfort with bioinformatics for single cell/NGS datasets and correlative biomarker discovery
- Prior participation in IND-enabling or early-phase clinical translation
KUCC offers integrated cGMP cell manufacturing, AAALAC-accredited vivaria, advanced cytometry (spectral flow, CyTOF), imaging cores, and biostatistics/bioinformatics support. The Division partners closely with clinical programs in hematologic malignancies and cellular therapeutics and IAMI to generate IEC discoveries and with the GMP lab, to accelerate bedside-to-bench-to-bedside translation.
Benefits and compensation
- Recent increase in overall compensation package
- Comprehensive retirement program
- Relocation assistance
- Health, dental, vision insurance with coverage day one
- CME allowance
- LTD/STD and Life insurance
- Professional liability insurance
The University of Kansas Cancer Center (KUCC) is the only NCI-designated Comprehensive Cancer Center in the region, serving patients across Kansas and western Missouri. Our…
To View & Apply for jobs on this site that accept applications from your location or country, tap the button below to make a Search.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
Search for further Jobs Here:
×